Triggering Toll-Like Receptor 5 Signaling During Pneumococcal Superinfection Prevents the Selection of Antibiotic Resistance
The Journal of Infectious Diseases · 15.11.2024 · 230 (5) · e1126-e1135
DOI: 10.1093/infdis/jiae239 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 08.05.2024. Verfasst von Charlotte Costa und 5 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France. Hauptthemen laut MEDLINE: Superinfection, Streptococcus pneumoniae, Toll-Like Receptor 5, Anti-Bacterial Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Inserm, Swiss National Science Foundation, Portuguese Foundation for Science and Technology.
Abstract (Originalsprache)
Toll-like receptor 5 (TLR5) signaling plays a key role in antibacterial defenses. We previously showed that respiratory administration of flagellin, a potent TLR5 agonist, in combination with amoxicillin (AMX) improves the treatment of primary pneumonia or superinfection caused by AMX-sensitive or AMX-resistant Streptococcus pneumoniae. Here, the impact of adjunct flagellin therapy on antibiotic dose/regimen and the selection of antibiotic-resistant S. pneumoniae was investigated using superinfection with isogenic antibiotic-sensitive and antibiotic-resistant bacteria and population dynamics analysis. Our findings demonstrate that flagellin allows for a 200-fold reduction in the antibiotic dose, achieving the same therapeutic effect observed with antibiotic alone. Adjunct treatment also reduced the selection of antibiotic-resistant bacteria in contrast to the antibiotic monotherapy. A mathematical model was developed that captured the population dynamics and estimated a 20-fold enhancement immune-modulatory factor on bacterial clearance. This work paves the way for the development of host-directed therapy and refinement of treatment by modeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, Lille, France.
- Department of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
- Center for Computational and Stochastic Mathematics, Instituto Superior Técnico, Universidade de Lisboa, Lisbon, Portugal.
ORCID-Profile: Charlotte Costa, Jean-Claude Sirard, Paddy S Gibson, Jan-Willem Veening, Erida Gjini, Mara Baldry
Förderung
- Inserm
- Swiss National Science Foundation
- Portuguese Foundation for Science and Technology
Zitieren
APA
Costa, C., Sirard, J. C., Gibson, P. S., Veening, J. W., Gjini, E., & Baldry, M. (2024). Triggering Toll-Like Receptor 5 Signaling During Pneumococcal Superinfection Prevents the Selection of Antibiotic Resistance. The Journal of Infectious Diseases, 230(5), e1126-e1135. https://doi.org/10.1093/infdis/jiae239
Vancouver
Costa C, Sirard JC, Gibson PS, Veening JW, Gjini E, Baldry M. Triggering Toll-Like Receptor 5 Signaling During Pneumococcal Superinfection Prevents the Selection of Antibiotic Resistance. The Journal of Infectious Diseases. 2024;230(5):e1126-e1135. doi:10.1093/infdis/jiae239
BibTeX
@article{Costa2024,
author = {Costa, Charlotte and Sirard, Jean-Claude and Gibson, Paddy S and Veening, Jan-Willem and Gjini, Erida and Baldry, Mara},
title = {Triggering Toll-Like Receptor 5 Signaling During Pneumococcal Superinfection Prevents the Selection of Antibiotic Resistance},
journal = {The Journal of Infectious Diseases},
year = {2024},
volume = {230},
number = {5},
pages = {e1126--e1135},
doi = {10.1093/infdis/jiae239}
}
EUVIMED